TMEM16A Antagonism: Therapeutic Potential with Desensitization of β-agonist Responsiveness in Asthma

Wu, A., Kuforiji, A., Zhang, Y., Xu, D., Perez-Zoghbi, J., Emala, C., & Danielsson, J. (2024). TMEM16A Antagonism: Therapeutic Potential with Desensitization of β-agonist Responsiveness in Asthma. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2024-0231oc
Authors:
Amy Wu
Aisha Kuforiji
Yi Zhang
Dingbang Xu
Jose Perez-Zoghbi
Charles Emala
Jennifer Danielsson
Affiliated Authors:
Amy Wu
Aisha Kuforiji
Yi Zhang
Dingbang Xu
Jose Perez-Zoghbi
Charles Emala
Jennifer Danielsson
Columbia Affiliation:
Author Keywords:
anoctamin
t16ainh-a01
benzbromarone
calcium-activated chloride channel
precision cut lung slice
elink
Publication Type:
Article
Unique ID:
10.1165/rcmb.2024-0231oc
PMID:
39560606
DOI:
10.1165/rcmb.2024-0231oc
Journal:
American Journal of Respiratory Cell and Molecular Biology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: